📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Actimis Pharmaceuticals

1.1 - Company Overview

Actimis Pharmaceuticals Logo

Actimis Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of small molecule therapeutics for respiratory and inflammatory disorders; a start-up biopharmaceutical company spun off from Bayer Healthcare AG's respiratory diseases therapeutic research portfolio, founded by Dr. Kevin Bacon.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Actimis Pharmaceuticals

Meda Pharma Logo

Meda Pharma

HQ: United States Website
  • Description: Provider of pharmaceutical products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Meda Pharma company profile →
Nutra Pharma Logo

Nutra Pharma

HQ: United States Website
  • Description: Provider of biopharmaceutical products, engaging in the acquisition, licensing, and commercialization of pharmaceutical products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nutra Pharma company profile →
Stada Logo

Stada

HQ: Germany Website
  • Description: Provider of pharmaceuticals and non-prescription consumer health products, operating on three pillars: OTC consumer healthcare, generics, and specialty pharmaceuticals. Sells products in over 120 countries, including acetaminophen, lactulose, Grippostad-C, Vitaprost, Cardiomagnyl, Xefocam Rapid, Aqualor, Edarbi, and Levomekol.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stada company profile →
Roivant Logo

Roivant

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines and healthcare technologies, developing VTAMA (tapinarof) cream for plaque psoriasis and atopic dermatitis in adults and children 2+, Brepocitinib (TYK2/JAK1) for dermatomyositis and non-infectious uveitis, IMVT-1402 (FcRn inhibitor) for autoimmune diseases including Graves' disease, Namilumab for sarcoidosis, and Mosliciguat for pulmonary hypertension associated with interstitial lung disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Roivant company profile →
Perrigo Logo

Perrigo

HQ: Ireland Website
  • Description: Provider of a variety of over-the-counter and generic prescription pharmaceuticals as a pharmaceutical and consumer goods company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Perrigo company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Actimis Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Actimis Pharmaceuticals

2.2 - Growth funds investing in similar companies to Actimis Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Actimis Pharmaceuticals

4.2 - Public trading comparable groups for Actimis Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Actimis Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Actimis Pharmaceuticals

What does Actimis Pharmaceuticals do?

Actimis Pharmaceuticals is a provider of small molecule therapeutics for respiratory and inflammatory disorders; a start-up biopharmaceutical company spun off from Bayer Healthcare AG's respiratory diseases therapeutic research portfolio, founded by Dr. Kevin Bacon.

Who are Actimis Pharmaceuticals's competitors?

Actimis Pharmaceuticals's competitors and similar companies include Meda Pharma, Nutra Pharma, Stada, Roivant, and Perrigo.

Where is Actimis Pharmaceuticals headquartered?

Actimis Pharmaceuticals is headquartered in United States.

How many employees does Actimis Pharmaceuticals have?

Actimis Pharmaceuticals has 1,000 employees 🔒.

When was Actimis Pharmaceuticals founded?

Actimis Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Actimis Pharmaceuticals in?

Actimis Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Actimis Pharmaceuticals

Who are the top strategic acquirers in Actimis Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Actimis Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Actimis Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Actimis Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Actimis Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Actimis Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Actimis Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Actimis Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Actimis Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Actimis Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Actimis Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Actimis Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Actimis Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Actimis Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Actimis Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Actimis Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Actimis Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Actimis Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Actimis Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Actimis Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Actimis Pharmaceuticals

Launch login modal Launch register modal